GlassScriptPhysician profile
David Ritz
NPI 1427585660
$4,585.66
in general payments reported to CMS, 2019-2025
7 companies · $86.19 in 2025
The $86.19 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $359 · 2024: $4,140 · 2025: $86.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,385 · Food and Beverage: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,384.73 |
| Food and Beverage | $700.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,164.74 | 2023-2025 | Da Vinci Surgical System |
| Kerecis Limited | $238.76 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Prytime Medical Devices, INC. | $84.81 | 2024 | Er-Reboa Plus |
| Davol INC. | $35.48 | 2025 | Phasix Mesh |
| Distalmotion US | $21.71 | 2025 | Dexter L6 Robot |
| W. L. Gore & Associates, INC. | $20.31 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Janssen Pharmaceuticals, INC | $19.85 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ritz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.